1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Biopsy 1.2.3 Imaging 1.2.4 Others 1.3 Market by Application 1.3.1 Global Melanoma Skin Cancer Diagnostic Testing Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Dermatology Clinics 1.3.4 Diagnostic Laboratories 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Melanoma Skin Cancer Diagnostic Testing Market Perspective (2017-2028) 2.2 Melanoma Skin Cancer Diagnostic Testing Growth Trends by Region 2.2.1 Melanoma Skin Cancer Diagnostic Testing Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Melanoma Skin Cancer Diagnostic Testing Historic Market Size by Region (2017-2022) 2.2.3 Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Region (2023-2028) 2.3 Melanoma Skin Cancer Diagnostic Testing Market Dynamics 2.3.1 Melanoma Skin Cancer Diagnostic Testing Industry Trends 2.3.2 Melanoma Skin Cancer Diagnostic Testing Market Drivers 2.3.3 Melanoma Skin Cancer Diagnostic Testing Market Challenges 2.3.4 Melanoma Skin Cancer Diagnostic Testing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Melanoma Skin Cancer Diagnostic Testing Players by Revenue 3.1.1 Global Top Melanoma Skin Cancer Diagnostic Testing Players by Revenue (2017-2022) 3.1.2 Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Players (2017-2022) 3.2 Global Melanoma Skin Cancer Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Melanoma Skin Cancer Diagnostic Testing Revenue 3.4 Global Melanoma Skin Cancer Diagnostic Testing Market Concentration Ratio 3.4.1 Global Melanoma Skin Cancer Diagnostic Testing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Melanoma Skin Cancer Diagnostic Testing Revenue in 2021 3.5 Melanoma Skin Cancer Diagnostic Testing Key Players Head office and Area Served 3.6 Key Players Melanoma Skin Cancer Diagnostic Testing Product Solution and Service 3.7 Date of Enter into Melanoma Skin Cancer Diagnostic Testing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Melanoma Skin Cancer Diagnostic Testing Breakdown Data by Type 4.1 Global Melanoma Skin Cancer Diagnostic Testing Historic Market Size by Type (2017-2022) 4.2 Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Type (2023-2028) 5 Melanoma Skin Cancer Diagnostic Testing Breakdown Data by Application 5.1 Global Melanoma Skin Cancer Diagnostic Testing Historic Market Size by Application (2017-2022) 5.2 Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Melanoma Skin Cancer Diagnostic Testing Market Size (2017-2028) 6.2 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2017-2022) 6.3 North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Melanoma Skin Cancer Diagnostic Testing Market Size (2017-2028) 7.2 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2017-2022) 7.3 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Market Size (2017-2028) 8.2 Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2017-2022) 8.3 Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Melanoma Skin Cancer Diagnostic Testing Market Size (2017-2028) 9.2 Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2017-2022) 9.3 Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size (2017-2028) 10.2 Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2017-2022) 10.3 Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Myriad Genetics 11.1.1 Myriad Genetics Company Detail 11.1.2 Myriad Genetics Business Overview 11.1.3 Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Introduction 11.1.4 Myriad Genetics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) 11.1.5 Myriad Genetics Recent Development 11.2 Abbott Laboratories 11.2.1 Abbott Laboratories Company Detail 11.2.2 Abbott Laboratories Business Overview 11.2.3 Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Introduction 11.2.4 Abbott Laboratories Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) 11.2.5 Abbott Laboratories Recent Development 11.3 Foundation Medicine 11.3.1 Foundation Medicine Company Detail 11.3.2 Foundation Medicine Business Overview 11.3.3 Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Introduction 11.3.4 Foundation Medicine Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) 11.3.5 Foundation Medicine Recent Development 11.4 Pathway Genomics Corporation 11.4.1 Pathway Genomics Corporation Company Detail 11.4.2 Pathway Genomics Corporation Business Overview 11.4.3 Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Introduction 11.4.4 Pathway Genomics Corporation Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) 11.4.5 Pathway Genomics Corporation Recent Development 11.5 Cancer Genetics 11.5.1 Cancer Genetics Company Detail 11.5.2 Cancer Genetics Business Overview 11.5.3 Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Introduction 11.5.4 Cancer Genetics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) 11.5.5 Cancer Genetics Recent Development 11.6 Castle Biosciences 11.6.1 Castle Biosciences Company Detail 11.6.2 Castle Biosciences Business Overview 11.6.3 Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Introduction 11.6.4 Castle Biosciences Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) 11.6.5 Castle Biosciences Recent Development 11.7 NeoGenomics 11.7.1 NeoGenomics Company Detail 11.7.2 NeoGenomics Business Overview 11.7.3 NeoGenomics Melanoma Skin Cancer Diagnostic Testing Introduction 11.7.4 NeoGenomics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) 11.7.5 NeoGenomics Recent Development 11.8 Dermtech 11.8.1 Dermtech Company Detail 11.8.2 Dermtech Business Overview 11.8.3 Dermtech Melanoma Skin Cancer Diagnostic Testing Introduction 11.8.4 Dermtech Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) 11.8.5 Dermtech Recent Development 11.9 Sysmex Inostics 11.9.1 Sysmex Inostics Company Detail 11.9.2 Sysmex Inostics Business Overview 11.9.3 Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Introduction 11.9.4 Sysmex Inostics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) 11.9.5 Sysmex Inostics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Biopsy Table 3. Key Players of Imaging Table 4. Key Players of Others Table 5. Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Melanoma Skin Cancer Diagnostic Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Region (2017-2022) Table 9. Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Region (2023-2028) Table 11. Melanoma Skin Cancer Diagnostic Testing Market Trends Table 12. Melanoma Skin Cancer Diagnostic Testing Market Drivers Table 13. Melanoma Skin Cancer Diagnostic Testing Market Challenges Table 14. Melanoma Skin Cancer Diagnostic Testing Market Restraints Table 15. Global Melanoma Skin Cancer Diagnostic Testing Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Players (2017-2022) Table 17. Global Top Melanoma Skin Cancer Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Skin Cancer Diagnostic Testing as of 2021) Table 18. Ranking of Global Top Melanoma Skin Cancer Diagnostic Testing Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Melanoma Skin Cancer Diagnostic Testing Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Melanoma Skin Cancer Diagnostic Testing Product Solution and Service Table 22. Date of Enter into Melanoma Skin Cancer Diagnostic Testing Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Type (2017-2022) Table 26. Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Type (2023-2028) Table 28. Global Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Application (2017-2022) Table 30. Global Melanoma Skin Cancer Diagnostic Testing Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Application (2023-2028) Table 32. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2023-2028) & (US$ Million) Table 42. Myriad Genetics Company Detail Table 43. Myriad Genetics Business Overview Table 44. Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Product Table 45. Myriad Genetics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) & (US$ Million) Table 46. Myriad Genetics Recent Development Table 47. Abbott Laboratories Company Detail Table 48. Abbott Laboratories Business Overview Table 49. Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Product Table 50. Abbott Laboratories Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) & (US$ Million) Table 51. Abbott Laboratories Recent Development Table 52. Foundation Medicine Company Detail Table 53. Foundation Medicine Business Overview Table 54. Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Product Table 55. Foundation Medicine Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) & (US$ Million) Table 56. Foundation Medicine Recent Development Table 57. Pathway Genomics Corporation Company Detail Table 58. Pathway Genomics Corporation Business Overview Table 59. Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Product Table 60. Pathway Genomics Corporation Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) & (US$ Million) Table 61. Pathway Genomics Corporation Recent Development Table 62. Cancer Genetics Company Detail Table 63. Cancer Genetics Business Overview Table 64. Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Product Table 65. Cancer Genetics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) & (US$ Million) Table 66. Cancer Genetics Recent Development Table 67. Castle Biosciences Company Detail Table 68. Castle Biosciences Business Overview Table 69. Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Product Table 70. Castle Biosciences Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) & (US$ Million) Table 71. Castle Biosciences Recent Development Table 72. NeoGenomics Company Detail Table 73. NeoGenomics Business Overview Table 74. NeoGenomics Melanoma Skin Cancer Diagnostic Testing Product Table 75. NeoGenomics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) & (US$ Million) Table 76. NeoGenomics Recent Development Table 77. Dermtech Company Detail Table 78. Dermtech Business Overview Table 79. Dermtech Melanoma Skin Cancer Diagnostic Testing Product Table 80. Dermtech Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) & (US$ Million) Table 81. Dermtech Recent Development Table 82. Sysmex Inostics Company Detail Table 83. Sysmex Inostics Business Overview Table 84. Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Product Table 85. Sysmex Inostics Revenue in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) & (US$ Million) Table 86. Sysmex Inostics Recent Development Table 87. Research Programs/Design for This Report Table 88. Key Data Information from Secondary Sources Table 89. Key Data Information from Primary Sources List of Figures Figure 1. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Type: 2021 VS 2028 Figure 2. Biopsy Features Figure 3. Imaging Features Figure 4. Others Features Figure 5. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Application in 2021 & 2028 Figure 6. Hospitals Case Studies Figure 7. Dermatology Clinics Case Studies Figure 8. Diagnostic Laboratories Case Studies Figure 9. Others Case Studies Figure 10. Melanoma Skin Cancer Diagnostic Testing Report Years Considered Figure 11. Global Melanoma Skin Cancer Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Melanoma Skin Cancer Diagnostic Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Region: 2021 VS 2028 Figure 14. Global Melanoma Skin Cancer Diagnostic Testing Market Share by Players in 2021 Figure 15. Global Top Melanoma Skin Cancer Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Skin Cancer Diagnostic Testing as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Melanoma Skin Cancer Diagnostic Testing Revenue in 2021 Figure 17. North America Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. North America Melanoma Skin Cancer Diagnostic Testing Market Share by Country (2017-2028) Figure 19. United States Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Melanoma Skin Cancer Diagnostic Testing Market Share by Country (2017-2028) Figure 23. Germany Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. France Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. U.K. Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Italy Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Russia Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Nordic Countries Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Melanoma Skin Cancer Diagnostic Testing Market Share by Region (2017-2028) Figure 31. China Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Japan Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. South Korea Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Southeast Asia Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. India Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Australia Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Melanoma Skin Cancer Diagnostic Testing Market Share by Country (2017-2028) Figure 39. Mexico Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Brazil Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Share by Country (2017-2028) Figure 43. Turkey Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Saudi Arabia Melanoma Skin Cancer Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Myriad Genetics Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) Figure 46. Abbott Laboratories Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) Figure 47. Foundation Medicine Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) Figure 48. Pathway Genomics Corporation Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) Figure 49. Cancer Genetics Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) Figure 50. Castle Biosciences Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) Figure 51. NeoGenomics Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) Figure 52. Dermtech Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) Figure 53. Sysmex Inostics Revenue Growth Rate in Melanoma Skin Cancer Diagnostic Testing Business (2017-2022) Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed

Myriad Genetics Abbott Laboratories Foundation Medicine Pathway Genomics Corporation Cancer Genetics Castle Biosciences NeoGenomics Dermtech Sysmex Inostics